Yanlong W. Pei
Guelph, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Efficient and safe lung gene delivery using AAV6.2FF in neonatal pigs demonstrates pediatric translational potential.
Journal: Molecular therapy. Advances
Published: September 09, 2025
Lung-tropic dual AAV-SP-C and microRNA gene therapy attenuates lung injury in mutant Sftpc mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 29, 2025
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
Journal: Journal of virology
Published: January 16, 2025
Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B-Deficient Mice.
Journal: American journal of respiratory cell and molecular biology
Published: January 13, 2025
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.
Journal: Vaccines
Published: March 01, 2024
Analysis of the impact of pluronic acid on the thermal stability and infectivity of AAV6.2FF.
Journal: BMC biotechnology
Published: November 22, 2023
AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumonia.
Journal: Gene therapy
Published: November 01, 2023
AAV-Vectored Expression of Marburg Virus-Neutralizing Antibody MR191 Provides Complete Protection From Challenge in a Guinea Pig Model.
Journal: The Journal of infectious diseases
Published: August 28, 2023
Last Updated: 09/26/2026